Pathogenic Mechanisms of Neurodegeneration in Parkinson Disease

被引:103
作者
Mullin, Stephen [1 ]
Schapira, Anthony H. V. [1 ]
机构
[1] UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England
基金
英国惠康基金;
关键词
Parkinson disease; alpha-Synuclein; Lewy bodies; Mitochondrial dysfunction; AUTOSOMAL-DOMINANT PARKINSONISM; CHAPERONE-MEDIATED AUTOPHAGY; ALPHA-SYNUCLEIN AGGREGATION; G2019S LRRK2 MUTATION; LEWY BODY PATHOLOGY; GAUCHER-DISEASE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; COMPLEX-I; GENOMEWIDE ASSOCIATION;
D O I
10.1016/j.ncl.2014.09.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The last 2 decades represent a period of unparalleled advancement in the understanding of the pathogenesis of Parkinson disease (PD). The discovery of several forms of familial parkinsonism with mendelian inheritance has elucidated insights into the mechanisms underlying the degeneration of dopaminergic neurons of the substantia nigra that histologically characterize PD. alpha-Synuclein, the principal component of Lewy bodies, remains the presumed pathogen at the heart of the current model; however, concurrently, a diverse range of other mechanisms have been implicated. The creation of a coherent disease model will be crucial to the development of effective disease modifying therapies for sporadic PD.
引用
收藏
页码:1 / +
页数:18
相关论文
共 50 条
  • [21] Metals associated neurodegeneration in Parkinson's disease: Insight to physiological, pathological mechanisms and management
    Raj, Khadga
    Kaur, Pawandeep
    Gupta, G. D.
    Singh, Shamsher
    NEUROSCIENCE LETTERS, 2021, 753
  • [22] Ferroptosis and cell death mechanisms in Parkinson's disease
    Guiney, Stephanie J.
    Adlard, Paul A.
    Bush, Ashley I.
    Finkelstein, David I.
    Ayton, Scott
    NEUROCHEMISTRY INTERNATIONAL, 2017, 104 : 34 - 48
  • [23] An update on potential therapeutic strategies for Parkinson's disease based on pathogenic mechanisms
    Shen, Ting
    Pu, Jiali
    Si, Xiaoli
    Ye, Rong
    Zhang, Baorong
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (06) : 711 - 722
  • [24] Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease
    Biskup, Saskia
    West, Andrew B.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (07): : 625 - 633
  • [25] TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson's Disease
    He, Xin
    Xie, Yue
    Zheng, Qiongping
    Zhang, Zeyu
    Ma, Shanshan
    Li, Junyu
    Li, Mingtao
    Huang, Qiaoying
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [26] Markers of Neurodegeneration in Parkinson's Disease
    Nikitina, M. A.
    Alifirova, V. M.
    Borodina, S. O.
    Koroleva, E. S.
    NEUROCHEMICAL JOURNAL, 2023, 17 (03) : 338 - 348
  • [27] Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration
    Lau, Yuen-Sum
    Patki, Gaurav
    Das-Panja, Kaberi
    Le, Wei-Dong
    Ahmad, S. Omar
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2011, 33 (07) : 1264 - 1274
  • [28] Neuroinflammatory Responses and Parkinson’ Disease: Pathogenic Mechanisms and Therapeutic Targets
    Liuna Yang
    Kanming Mao
    Honglin Yu
    Jialong Chen
    Journal of Neuroimmune Pharmacology, 2020, 15 : 830 - 837
  • [29] Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process
    Karimi-Moghadam, Amin
    Charsouei, Saeid
    Bell, Benjamin
    Jabalameli, Mohammad Reza
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2018, 38 (06) : 1153 - 1178
  • [30] Advances in the Mechanisms of Parkinson's Disease
    Tolleson, Christopher M.
    Fang, John Y.
    DISCOVERY MEDICINE, 2013, 15 (80) : 61 - 66